-
Pharma Partnering Summit 2024 16-17 October, Boston, MA USA
Join the Symeres team at the Pharma Partnering Summit 2024 from Oct 16-17th in Boston, MA with Rory Curtis (VP Business Development), Paul O’Shea and Russ Thomas (Head of Business Development). We look forward to meeting you and discussing how we can support your drug discovery and development programs. The aim of the conference is to bring together senior executives and decision makers from across the global focused on Business Development & Licensing Opportunities, Commercialization Opportunities, Fundraising, Investments, R&D Collaborations, Alliances and Partnerships. We look forward to expanding our network, both new and old, while discovering new collaborative partners and opportunities within the biopharmaceutical industry.
-
Precision in Drug Discovery & Preclinical Summit 17-18 October, San Diego, USA
Join Symeres’ US Business Development team at the #PDDPSUMMIT in La Jolla, October 17-18! Our Business Development Directors, Bart DeCorte and Leah Haydock are excited to connect with partners and customers in the San Diego area for insightful discussions and new collaborations. Would you like to know about Symeres Drug Discovery and Development services? Curious about our expertise in small molecule R&D, or interested in our comprehensive ADME-Tox profiling and in vivo DMPK platforms? Don’t miss the chance to engage with Bart and Leah at the event or schedule a meeting in advance to discuss how Symeres can support your projects.
-
37th Annual Congress of the European Association of Nuclear Medicine 19-23 October, Hamburg, Germany
Symeres is excited to participate for the first time at the 37th Annual Congress of the European Association of Nuclear Medicine (EANM) in Hamburg. Sascha Hartmann, Director of Business Development, and Ton Visser, Team Leader at Symeres, are thrilled to be part of this prestigious event. This congress is the perfect platform to engage with leading experts, clinicians, and researchers, exchanging cutting-edge insights and innovations in the field of nuclear medicine. We’re looking forward to the scientific sessions on topics like molecular imaging, radiopharmaceuticals, and theranostics. Curious about Symeres’ expertise in the design and synthesis of precursors for positron emission tomography (PET)? Interested in learning more about our expertise in labelling? Feel free to reach out to Ton and Sascha—they’ll be happy to share more details!
-
Bio Europe 2024 4-6 November, Stockholm, Sweden
Symeres will be present at BioEurope 2024 from Nov 4-6, 2024 in Stockholm, Sweden. Our team consisting of Sascha Hartmann, Norimasa Morita, and Ana Rioz are excited to meet you! Come learn how our organic chemistry expertise can benefit you from early drug discovery to manufacturing needs. This important event celebrates 30 years of facilitating partnerships with 5,500 attendees representing more than 2,800 companies from different countries. Are you interested in connecting? Please feel free to connect with us on Linkedln to arrange a meeting or get in touch with us at the event!
-
Discovery US 2024 7-8 November, Boston, USA
Symeres will be present at Discovery US 2024 from Nov 7-8, 2024 in Boston, USA. Our team consisting of Leah Haydock, Miia Kovalainen and Chris Teleha will be happy to meet you there! Our team of over 500+ knowledgeable scientists will help you research, design and strategize the best molecule for your discovery needs. This event focuses on connecting experts in biology and chemistry to advance small molecule drug discovery. This event will provide a platform for interesting discussions related to early drug discovery in terms of technology, latest research and more. Like our slogan “Making Molecules Matter. Together.” reflects, Symeres has specialized in designing and producing small molecules for over 25 years, making us a partner of choice for many. We look forward to seeing past and current partners, while also meeting new connections.
Feel free to contact us!
Curious to know more about what can we do for you? Get in touch and let’s start a conversation.